{"denomUnitsSelected":"Participants","description":"The number of participants who continue on Daratumumab and Dexamethasone after 2 cycles","reportingStatus":"NOT_POSTED","timeFrame":"At the end of Cycle 2 (each cycle is 28 days)","title":"Number of Participants Who Continue on Arm A After 2 Cycles","type":"OTHER_PRE_SPECIFIED"}